Premium
Mitotane (o, p‘‐DDD) treatment in a cat with hyperadrenocorticism
Author(s) -
Schwedes C. S.
Publication year - 1997
Publication title -
journal of small animal practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 67
eISSN - 1748-5827
pISSN - 0022-4510
DOI - 10.1111/j.1748-5827.1997.tb03310.x
Subject(s) - mitotane , medicine , diabetes mellitus , adverse effect , endocrinology , adrenocortical carcinoma
An 11‐year‐old male castrated Persian cat with spontaneous hyperadrenocorticism was presented. Both adrenals were grossly enlarged and calcified. A diagnosis of pituitary‐dependent hyperadrenocorticism was made. Signs of hyperadrenocorticism resolved with long‐term mitotane treatment. Concurrent diabetes mellitus resolved after 220 days of therapy. No severe adverse drug reactions were noted.